Загрузка...

Nivolumab-Associated Acute Demyelinating Encephalitis: A Case Report and Literature Review

Nivolumab is a checkpoint inhibiting immunotherapeutic agent prescribed for the treatment of resistant cancers. Many immune-related adverse effects including neurological effects have been described, but central nervous system (CNS) toxicities are rarely reported. We present a 59-year-old Caucasian...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Med Res
Главные авторы: Zafar, Zubair, Vogler, Carrie, Hudali, Tamer, Bhattarai, Mukul
Формат: Artigo
Язык:Inglês
Опубликовано: Marshfield Clinic 2019
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6546281/
https://ncbi.nlm.nih.gov/pubmed/31160476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2019.1417
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!